logo
15:59 Dec 05

Gland Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1751.60
+16.70 (+0.96%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Gland Pharma Ltd. Financials

Gland Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1751.60
+16.70 (+0.96%)
15:59 Dec 05
Quality
image/svg+xml

70/100
High Financial Strength

Valuation
image/svg+xml

36/100
Mid Valuation

Technical

45/100
Technically Neutral

Strength

3

Weakness

8

Opportunity

2

Threats

1

7.63 %

ROE %

6.22 %

ROA %

47.97

EPS

555.40

BVPS

12.43 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
4400.71 3624.6 5664.72 5616.5 5720.41
Operating Expenses +
2890.55 2599.83 4331.65 4347.58 4348.15
Raw Material
2072.52 1732.34 2275.2 2186.12 2076.98
Increase Decrease in Cost
36.69 -46.92 127.88 103.41 -29.71
Other Manufacturing Expense
95.05 124.84 0 0 198.3
Employee Cost
338.57 403.26 1256.89 1401.56 1454.08
Miscellaneous Expenses
399.04 417.49 717.82 685.47 648.5
Operating Profit
1510.16 1024.77 1333.07 1268.92 1372.26
Other Income
223.94 240.46 170.24 213.61 219.71
Depreciation
110.3 146.74 344.57 377.87 386.96
Interest
5.24 7.45 26.2 42 47.88
Profit before tax and exceptio..
1618.55 1111.04 1132.54 1062.66 1157.13
Exceptional Items
0 -56.46 0 0 0
PBT
1618.55 1054.58 1132.54 1062.66 1157.13
Provision for Taxation
406.89 273.54 360.08 364.13 386.91
Net Profit
1211.66 781.04 772.46 698.53 770.24
NET Profit after MI
1211.66 781.04 772.46 698.53 770.24
EPS
73.81 47.43 46.9 42.4 46.75
Operating Profit Margin (%)
34.32 28.27 23.53 22.59 23.99
Net Profit Margin (%)
27.53 21.55 13.64 12.44 13.46

Gland Pharma Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: